ArticleMaterials today. Bio2025
Nanotube topography inhibits NLRP3 inflammasome activation by reducing microtubule glutamylation.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The topography of the implant surface is critical in modulating the inflammatory immune environment and serves as a crucial determinant for the success of osseointegration. Immune cells, particularly macrophages, are capable of detecting mechanical alterations in the implant surface topography through their cytoskeletal network, with microtubules being integral components in the mechanosensing process. Nevertheless, the mechanisms by which macrophages regulate microtubule dynamics in response to surface morphology and subsequently remodel the local immune environment remain elusive. This study employs titanium dioxide nanotubes (TNTs) to investigate the macrophage responses to implant morphology. The results demonstrate that the distinctive topography of TNTs disrupts microtubule stability and organization, diminishes microtubule polyglutamylation levels and consequently inhibits NLRP3 inflammasome assembly and activation. Upregulation of microtubule glutamylation levels reverses TNT-mediated inhibition of NLRP3 inflammasome activation. Additionally, TNTs suppress the expression of microtubule-associated kinase 4 (MARK4), which is closely related to microtubule function. Further investigation reveals that TNT-induced MARK4 downregulation reduces microtubule glutamylation, thereby preventing excessive activation of the NLRP3 inflammasome. Consistent with the in vitro findings, in a rat model of oral peri-implantitis, implants with nanotube topologies showed reduced NLRP3 inflammasome activation, as well as decreased MARK4 expression and microtubule glutamylation at the implant surface. This study is the first to demonstrate that microtubule glutamylation is involved in the assembly and activation of the NLRP3 inflammasome, offering valuable insights for the design of implants with enhanced osteoimmunomodulatory properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.